TAMSULOSIN FOR TREATING LOWER URINARY TRACT SYMPTOMS COMPATIBLE WITH BENIGN PROSTATIC OBSTRUCTION: A SYSTEMATIC REVIEW OF EFFICACY AND ADVERSE EFFECTS
Author:
Affiliation:
1. From the Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research, Cochrane Review Group in Prostate Diseases and Urologic Cancers, Veterans Affairs Medical Center, Minneapolis, Minnesota
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference29 articles.
1. High prevalence of benign prostatic hypertrophy in the community;Garraway;Lancet,1991
2. The prevalence of prostatism: a population-based survey of urinary symptoms;Chute;J Urol,1993
3. Transurethral prostatectomy: practice aspects of the dominant operation in American urology;Holtgrewe;J Urol,1989
4. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer;Barry;J Urol,1997
5. Drug treatment for benign prostatic hyperplasia. Health authorities must audit use of finasteride;Mendelsohn;BMJ,1997
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Use of alpha‐adrenergic antagonists for lower urinary tract symptoms is not associated with worsening cognitive function;Neurourology and Urodynamics;2024-05-27
2. Risks and side effects in the medical management of benign prostatic hyperplasia;Prostate International;2023-12
3. Association between PRO 160/120 prescriptions and incidence of benign prostatic hyperplasia complications in Germany: a retrospective cohort study;Postgraduate Medicine;2022-11-21
4. Evaluation of intermittent tamsulosin in treating symptomatic patients with benign prostatic hyperplasia;Urology Annals;2022-11-08
5. Oral pharmacological treatments for chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis of randomised controlled trials;eClinicalMedicine;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3